Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NVO [NYSE]
Novo Nordisk A/S
Index- P/E26.16 EPS (ttm)1.73 Insider Own- Shs Outstand2.18B Perf Week5.09%
Market Cap98.82B Forward P/E21.00 EPS next Y2.16 Insider Trans- Shs Float1.59B Perf Month3.08%
Income4.66B PEG2.04 EPS next Q0.44 Inst Own8.10% Short Float0.27% Perf Quarter19.36%
Sales15.46B P/S6.39 EPS this Y19.60% Inst Trans1.06% Short Ratio2.45 Perf Half Y32.85%
Book/sh3.09 P/B14.64 EPS next Y12.42% ROA38.00% Target Price49.09 Perf Year38.85%
Cash/sh1.22 P/C37.23 EPS next 5Y12.80% ROE66.80% 52W Range29.35 - 47.53 Perf YTD24.76%
Dividend0.61 P/FCF42.81 EPS past 5Y24.60% ROI56.40% 52W High-4.79% Beta0.99
Dividend %1.35% Quick Ratio1.30 Sales past 5Y12.90% Gross Margin83.10% 52W Low54.16% ATR0.75
Employees37978 Current Ratio1.70 Sales Q/Q3.50% Oper. Margin37.70% RSI (14)57.24 Volatility1.31% 1.33%
OptionableYes Debt/Eq0.01 EPS Q/Q5.00% Profit Margin29.90% Rel Volume0.44 Prev Close44.54
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout35.40% Avg Volume1.72M Price45.25
Recom2.00 SMA202.22% SMA501.52% SMA20022.58% Volume789,900 Change1.59%
28-May-13Upgrade Deutsche Bank Sell → Hold
31-Mar-10Initiated Deutsche Bank Hold
30-Mar-10Downgrade Mehta Partners Outperform → Market Perform
24-Feb-10Upgrade Jefferies & Co Hold → Buy
15-Jan-10Downgrade Jefferies & Co Buy → Hold
11-Sep-09Initiated Jefferies & Co Buy
07-Aug-09Downgrade UBS Buy → Neutral
07-Aug-09Downgrade JP Morgan Overweight → Neutral
12-May-09Initiated Piper Jaffray Buy
24-Apr-09Upgrade Citigroup Hold → Buy
26-Mar-09Upgrade UBS Neutral → Buy
14-Jan-09Downgrade Citigroup Hold → Sell
06-Oct-08Upgrade Deutsche Securities Hold → Buy
29-Aug-08Downgrade Bernstein Mkt Perform → Underperform
21-Aug-08Initiated UBS Neutral
09-Jun-08Upgrade HSBC Securities Underweight → Neutral
26-Feb-08Downgrade Bear Stearns Outperform → Peer Perform
08-Feb-08Upgrade Bernstein Mkt Perform → Outperform
23-Jan-08Upgrade Bear Stearns Peer Perform → Outperform
09-Aug-07Downgrade Lehman Brothers Overweight → Equal-weight
16-Apr-14 08:07AM  Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi? at Seeking Alpha
15-Apr-14 04:25PM  Eli Lilly/ Boehringer Drug Under FDA Review Zacks
04:20PM  Encouraging Results from Lexicon Candidate Zacks
14-Apr-14 05:48PM  MannKind's Overly-Optimisitic Investors at Motley Fool
09-Apr-14 08:02AM  Alexion, Biogen Among Leading Big-Cap Biotechs at Investor's Business Daily
08-Apr-14 02:30PM  Does Biogen Idec Inc Have a New Blockbuster Hemophilia Therapy? at Motley Fool
03-Apr-14 06:13PM  Salix Among Stocks Getting Support At 10-Week Line at Investor's Business Daily
05:57PM  David Letterman Announces Retirement at The Wall Street Journal
05:12PM  [$$] AIG Sues State Financial Regulator in Licensing Dispute at The Wall Street Journal
04:28PM  [$$] Micron Technology Swings to Profit at The Wall Street Journal
04:06PM  [$$] Globalfoundries Emerges as Lead Candidate to Buy IBM Chip Plants at The Wall Street Journal
03:32PM  [$$] Ford Outpaces Bigger Rivals in China at The Wall Street Journal
02:57PM  Turkey Lifts Block on Twitter After Court Ruling at The Wall Street Journal
02:22PM  [$$] Kashagan Unlikely to Restart This Summer at The Wall Street Journal
01:34PM  [$$] MPS Sells More of Monte dei Paschi Stake at The Wall Street Journal
12:57PM  [$$] Intel CEO's Compensation Fell in 2013 at The Wall Street Journal
12:13PM  Police Ask Singapore-Listed Firms to Assist in Probe at The Wall Street Journal
11:40AM  [$$] Fresenius Medical Care Expects Revenue to Grow to $28 Billion by 2020 at The Wall Street Journal
10:59AM  [$$] Banco Sabadell Wants to Spin Off Solvia at The Wall Street Journal
09:32AM  Will Biogen Idec Inc. Rule Biotech in 2014? at Motley Fool
02-Apr-14 06:32PM  Positive Panel, but 3 Risks Remain for MannKind Corporation at Motley Fool
03:30PM  FDA Panel Positive on MannKind's Afrezza Zacks
09:08AM  Is It Too Early To Invest In Versartis? at Seeking Alpha
01-Apr-14 06:31PM  A New Frontier for Biogen Idec, Inc.? at Motley Fool
01:03PM  3 Stocks Underperforming Today In The Health Care Sector at TheStreet
09:31AM  MannKind Fails to Learn From Its Mistake at Motley Fool
31-Mar-14 03:45PM  MannKind Down on FDA's Briefing Document Zacks
03:10PM  No April Fool's Joke: MannKind's Critical Vote at Motley Fool
28-Mar-14 05:38AM  Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes CNW Group
27-Mar-14 10:37PM  MannKind's Upcoming Catalyst(s) at Motley Fool
06:41PM  Baxter Splitting In Effort To 'Unlock Trapped Value' at Investor's Business Daily
06:00PM  Glaxo's Eperzan Approved in EU Zacks
05:51PM  Drug, Airline Stocks Top Shortened Weekly Review at Investor's Business Daily
11:47AM  Will Baxter International Inc's Split Unlock Shareholder Value? at Motley Fool
11:15AM  Baxter To Split Into Two Companies; Stock Jumps at Investor's Business Daily
05:37AM  Biotech's Innate Issues at The Wall Street Journal
05:31AM  Biotech's Innate Issues at The Wall Street Journal
25-Mar-14 03:30PM  Positive CHMP Opinion for Novo Nordisk's Drugs Zacks
02:32PM  Last Week's Biopharma R&D Winners at Motley Fool
24-Mar-14 11:43AM  Novo Nordisk Upgraded to 'Buy' at Fox Business
20-Mar-14 11:50AM  Positive Data on Novo Nordisk's N8-GP Zacks
19-Mar-14 03:50PM  Novo Nordisk Extends Diabetes Operations Zacks
17-Mar-14 05:41AM  Europe's Half-Empty Pharma Market at The Wall Street Journal
14-Mar-14 08:12AM  Novo Nordisk - An Opportune Time To Book Profits at Seeking Alpha
08:12AM  Novo Nordisk - An Opportune Time To Book Profits
11-Mar-14 03:35PM  Eli Lilly - The 'Never Say Die' Pharmaceutical at Seeking Alpha
03:35PM  Eli Lilly - The 'Never Say Die' Pharmaceutical
10:30AM  New Diagnostic Test From Roche Zacks
10:30AM  New Diagnostic Test From Roche
05:30AM  Caisson Biotech Expands HEPtune Drug Delivery Deal with Novo Nordisk PR Newswire
10-Mar-14 06:32PM  Who Will Capture This $3.5 Billion Opportunity? at Motley Fool
04:19PM  Marco Rubio's Important New Proposal For Containing The Costs Of Federal Regulation at Forbes
03:50PM  Positive Data on Novartis' Jakavi Zacks
03:50PM  Positive Data on Novartis' Jakavi
09-Mar-14 06:31PM  Lilly Underwhelms Investors Again at Motley Fool
07-Mar-14 04:30PM  Label Expansion for Novartis' Xolair Zacks
04:30PM  Label Expansion for Novartis' Xolair
06-Mar-14 03:35PM  Encouraging Data from Roche Zacks
03:35PM  Encouraging Data from Roche
02:02PM  What Does This Rejection Mean for Eli Lilly? at Motley Fool
11:00AM  Regulatory Setback for Eli Lilly Zacks
08:25AM  Novo Nordisk (NVO) Enters Oversold Territory Zacks
05-Mar-14 06:31PM  Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co? at Motley Fool
04:50PM  Promising Data on Merck Allergy Drug Zacks
03:55PM  Update on Bayer/Regeneron's Eylea Zacks
04-Mar-14 02:56PM  Setback for Roche Zacks
02:31PM  Is This Drug Enough To Revive Hope in Eli Lilly's Pipeline? at Motley Fool
27-Feb-14 06:31PM  Eli Lilly's Dulaglutide: The Same, But Better at Motley Fool
03:45PM  Eli Lilly Gains Slightly on Dulaglutide Data Zacks
06:11AM  FDA eases worries regarding certain diabetes medications, AP says theflyonthewall.com
26-Feb-14 06:37PM  Drugmakers Like Jazz, Shire Key To Europe's Recovery at Investor's Business Daily
11:58AM  European stocks pull back from six-year high at MarketWatch
08:33AM  European stocks pull back from six-year highs at MarketWatch
04:55AM  European stocks pull back from six-year highs at MarketWatch
25-Feb-14 12:25PM  Clock Is Ticking For AstraZeneca at Forbes +5.25%
12:20PM  Stoxx 600 extends gains to six-year high; Novo rallies at MarketWatch
11:05AM  [$$] Apollo Considers Dive Into Debt at The Wall Street Journal
09:45AM  [$$] Government Open to Talks with América Móvil on Telekom Austria at The Wall Street Journal
08:15AM  [$$] Martha Stewart Earnings Soar on Lower Operating Expenses at The Wall Street Journal
24-Feb-14 08:00AM  Danish Dominance in an ETF ETF Trends
21-Feb-14 05:28PM  Drug Stocks Rally: Consider These Profitable Stocks As Pharmaceutical Deals Rise at TheStreet
12:31PM  Pharmacyclics Hits High As Imbruvica Launches Big at Investor's Business Daily
20-Feb-14 06:34PM  [$$] Citigroup Gives CEO 23% Pay Raise at The Wall Street Journal
04:46PM  How to Use Philosophy to Sell Stuff: An Innovation Firm's Advice at BusinessWeek
04:32PM  [$$] Hewlett-Packard Profit Rises 16% at The Wall Street Journal
03:04PM  [$$] Google Working on 3D Vision Smartphone Project at The Wall Street Journal
01:42PM  [$$] New Metric Casts J.P. Morgan Trading Losses in Harsher Light at The Wall Street Journal
12:43PM  [$$] Brooks Acquitted of One Bribery Charge at The Wall Street Journal
11:09AM  [$$] Madoff Claims JP Morgan Knew of Fraud at The Wall Street Journal
09:31AM  Stock Futures Erase Losses After U.S. Data at The Wall Street Journal
08:06AM  [$$] SocGen Appeals Euribor Fine at The Wall Street Journal
06:48AM  [$$] Brooks Acquitted of One Bribery Charge at The Wall Street Journal
05:37AM  [$$] Russian Arctic LNG Project to Name Shippers, Ports in March at The Wall Street Journal
03:56AM  [$$] Budget Cuts Bear Down on BAE at The Wall Street Journal
03:06AM  [$$] Suez Environnement's 2013 Net Rises at The Wall Street Journal
02:01AM  [$$] Air France Swings to Loss at The Wall Street Journal
01:00AM  [$$] Safran's 2013 Adjusted Net Profits Climb 22% at The Wall Street Journal
12:26AM  [$$] China Manufacturing Indicator Drops at The Wall Street Journal
19-Feb-14 11:27PM  Facebook to Buy WhatsApp for $19 Billion at The Wall Street Journal
10:44PM  [$$] China HSBC PMI Drops to Seven-Month Low at The Wall Street Journal
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.